Home › Funds › Carlyle Group Inc. › SPRB

Carlyle Group Inc. position in SPRB

SPRUCE BIOSCIENCES INC · Health Care

Carlyle Group Inc. reported holding 38,620 shares of SPRB (SPRUCE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 0.02% of its reported portfolio and ranking #6 among its reported holdings. Carlyle Group Inc. has disclosed SPRB holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)38.62K sh
Reported value held$1.88M
Portfolio Weight0.02%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Carlyle Group Inc.'s SPRB position evolved

Carlyle Group Inc. first disclosed a stake in SPRB in Q3 2023 at 2,896,518 shares (US$6.5M). The position peaked in Q3 2025 at 2,896,518 shares, worth US$24.8M. Across 12 filings, Carlyle Group Inc. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 38,620 shares valued at US$1.9M. Notable position changes include a 99% trim in Q4 2025 (shares fell 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.90M $6.46M New
Q4 2023 2.90M $8.37M Hold
Q1 2024 2.90M $2.28M Hold
Q2 2024 2.90M $1.52M Hold
Q3 2024 2.90M $1.32M Hold
Q4 2024 2.90M $1.22M Hold
Q1 2025 2.90M $840.28K Hold
Q3 2025 2.90M $24.77M New
Q4 2025 38.62K $3.30M Reduce
Q1 2026 38.62K $2.52M Hold
Q2 2026 38.62K $2.09M Hold
Q3 2026 38.62K $1.88M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SPRB and 13F data

SPRB (SPRUCE BIOSCIENCES INC) is a Health Care company. 57 other funds we track also report a position in SPRB — the largest reported positions include AIGH Capital Management LLC (US$12.1M), AWM Investment Company, Inc. (US$7.9M), Ikarian Capital, LLC (US$6.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SPRB

All SPRB fund holders →

FAQ

How long has Carlyle Group Inc. held SPRB?

Carlyle Group Inc. has disclosed SPRB holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Carlyle Group Inc.'s current position in SPRB?

As of Q3 2026, Carlyle Group Inc. holds 38.62K shares of SPRB (SPRUCE BIOSCIENCES INC), valued at $1.88M, representing 0.02% of its reported portfolio and ranking #6.

Has Carlyle Group Inc. been buying or selling SPRB?

In the latest 13F filing (Q3 2026), Carlyle Group Inc. held unchanged its position in SPRB. The position peaked in Q3 2025 at 2.90M shares.

Which other funds hold SPRB?

Other major institutional holders of SPRB include AIGH Capital Management LLC, AWM Investment Company, Inc., Ikarian Capital, LLC, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.